Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022

NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire

Spreading safe, cheap embolization around the world

Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice

R&D

Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.

Services

CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.

Training

Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.

Dernières Publications (5/371)

  1. Horowitz, T, Dudouet, P, Campion, JY, Kaphan, E, Radulesco, T, Gonzalez, S et al.. Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [18F]FDG-PET study. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06775-x. PubMed PMID:38862619 .
  2. Verger, A, Cecchin, D, Guedj, E, Albert, NL, Brendel, M, Fraioli, F et al.. EANM perspectives for CZT SPECT in brain applications. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06788-6. PubMed PMID:38858281 .
  3. Varoquaux, A, Fakhry, N, Scemama, U, Taïeb, D. Differentiation of vagal from carotid paraganglioma on unenhanced PET/CT: the “sweet potato” shape on PET. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06776-w. PubMed PMID:38829375 .
  4. Riviere, M, Brioude, G, Remond, V, Graille, I, Gaubert, JY, Habert, P et al.. [Imaging of actinomycosis: CT scan, bronchial embolization and pathology]. Rev Mal Respir. 2024;41 (6):446-450. doi: 10.1016/j.rmr.2024.05.002. PubMed PMID:38796385 .
  5. Connell, E, Gerard, É, Oules, B, Brunet-Possenti, F, Lamoureux, A, Bonnefille, H et al.. Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. Oncologist. 2024; :. doi: 10.1093/oncolo/oyae085. PubMed PMID:38761384 .
Search PubMed